Free tools, free alerts. Create a free account to get sector-matched alerts and save your searches.
Create free account →
NAFDAC has issued multiple alerts and public notices in August 2026 regarding substandard, falsified, and counterfeit products, as well as safety risks from certain drug combinations. These actions signal heightened regulatory scrutiny on product quality and safety, requiring Nigerian businesses in the pharmaceutical, healthcare, and consumer goods sectors to strengthen their compliance and due diligence measures.
Pharmaceuticals
Healthcare
Consumer Goods
Import/Export
Agriculture
Public Notice on Blacklisting Ayrtons Saunders Ltd, Uk
NAFDAC
NAFDAC blacklists Ayrtons Saunders Ltd, UK, and informs the public and stakeholders about this action.
Businesses dealing with products from this company must cease transactions and verify alternative suppliers to avoid regulatory penalties.
Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
NAFDAC
NAFDAC places products marketed by Mofus Nigeria Ltd on a watchlist pending investigation.
Distributors and retailers should halt sales of these products and await investigation outcomes to avoid liability.
Public Alert No. 042/2026-Alert on the Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
NAFDAC
NAFDAC alerts on the seizure of suspected substandard and falsified antimalarial medicine BPPL Artemether/Lumefantrine.
Pharmacies and healthcare providers must check their stock for this product and remove it from shelves to prevent patient harm and legal issues.
Public Alert No. 041/2026 – Alert on Suspected Counterfeit ORACIRE+ Toothpaste
NAFDAC
NAFDAC warns about suspected counterfeit ORACIRE+ toothpaste being distributed as ORACARE+.
Retailers and consumers should be vigilant and verify product authenticity; businesses should ensure their supply chains are secure to avoid selling counterfeit goods.
Public Alert No: 039/2026 – Alert on the Risk of Drug Poisoning Associated with Concurrent Use of Gabapentinoids and Other Medicines
NAFDAC
NAFDAC alerts on increased risk of drug poisoning when gabapentinoids are used with certain other medicines.
Healthcare providers and pharmacists must counsel patients on drug interactions and review prescriptions to prevent adverse events.
How to Register Your Fish Farm with NEPC Nigeria: A Complete Export Guide - within nigeria
Other
A guide on registering fish farms with NEPC for export purposes.
Fish farmers and exporters should follow the guide to ensure compliance with export regulations and access international markets.
Heightened enforcement against substandard and counterfeit products in the pharmaceutical and consumer goods sectors.
Need for robust supply chain due diligence to avoid association with blacklisted or investigated entities.
Increased focus on drug safety and pharmacovigilance, requiring proactive compliance.
Opportunities for compliant businesses to gain market trust and avoid disruptions.
Export-oriented businesses, like fish farms, must align with NEPC registration requirements.
1
Review and update supplier lists to exclude blacklisted or watchlisted companies.
2
Conduct internal audits of product inventory to identify and remove any flagged products.
3
Implement stricter quality control measures and verify product authenticity with NAFDAC.
4
Train staff on drug safety and counterfeit detection, especially for pharmaceuticals.
5
For fish farmers, initiate or complete NEPC registration to ensure export readiness.
6
Stay informed on NAFDAC alerts and adjust business practices accordingly.